ChemoCentryx, Inc. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2014-11-05: Form 8-K; Period of report 2014-11-05; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
- 2014-08-05: Form 8-K; Period of report 2014-08-05; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
- 2014-05-28: Form 8-K; Period of report 2014-05-22; Description 5.07 Submission of Matters to a Vote of Security Holders; Details 5.07.
- 2014-05-08: Form 8-K; Period of report 2014-05-08; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2014-11-05 | 8-K | 2014-11-05 | 2.02 Results of Operations and Financial Condition | 2.02 On November 5, 2014, ChemoCentryx, Inc. issued a press release announcing its financial results for the third quarter ended September 30, 2014. | d817659d8k.htm |
| 2014-08-05 | 8-K | 2014-08-05 | 2.02 Results of Operations and Financial Condition | 2.02 On August 5, 2014, ChemoCentryx, Inc. issued a press release announcing its financial results for the second quarter ended June 30, 2014. | d767199d8k.htm |
| 2014-05-28 | 8-K | 2014-05-22 | 5.07 Submission of Matters to a Vote of Security Holders | 5.07 ChemoCentryx, Inc. (the “Company”) held its annual meeting of stockholders on May 22, 2014. | d733965d8k.htm |
| 2014-05-08 | 8-K | 2014-05-08 | 2.02 Results of Operations and Financial Condition | 2.02 On May 8, 2014, ChemoCentryx, Inc. issued a press release announcing its financial results for the first quarter ended March 31, 2014. | d722380d8k.htm |
| 2014-03-13 | 8-K | 2014-03-13 | 2.02 Results of Operations and Financial Condition | 2.02 On March 13, 2014, ChemoCentryx, Inc. issued a press release announcing its financial results for the fourth quarter and year ended December 31, 2013. | d695058d8k.htm |
| 2014-02-21 | 8-K | 2014-02-19 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On February 19, 2014, the Compensation Committee (the “Committee”) of the Board of Directors (the “Board”) of ChemoCentryx, Inc. (the “Company”) established the base salaries to be paid to the executive officers listed below (the “Named Executive Officers”), effective January 1, 2014 and also approved cash bonus payments for the 2013 fiscal year to be paid to each of the Named Executive Officers and set target cash bonuses for the 2014 fiscal year for each of the Named Executive Officers. | d681465d8k.htm |